title: Safety considerations when choosing the appropriate treatment for patients with multiple sclerosis.
authors.affiliation: Hospital General Universitario de Alicante, Neurology Department , Calle Pintor Baeza 12, Alicante 03010 , Spain aperezs@mac.com.
authors.forename: Angel P
authors.initials: AP
authors.lastname: Sempere
authors.forename: Juana
authors.initials: J
authors.lastname: Gimenez-Martinez
mesh_terms: D017277:Drug Approval; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents
keywords: dimethyl fumarate; fingolimod; multiple sclerosis; safety; teriflunomide